［1］Rawish KR,Buza N,Zheng W,et al.Endometrial carcinoma with trophoblastic components:Clinicopathologic analysis of a rare entity［J/OL］.Int J Gynecol Pathol,2017,https://www.ncbi.nlm.nih.gov/pubmed/?term=Endometrial+Carcinoma+With+Trophoblastic+Components%3A+Clinicopathologic+Analysis+of+a+Rare+Entity.
［2］Nguyen TT,Kurita T,Koi C，et al.GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance［J］.Am J Cancer Res,2017,7(5):1188-1197.
［3］Guo Ruixia,Wei Lihui,Wang Jianlu,et al.17 beta estradiol for endometrial cancer cells phosphatidyl inositol 3 kinase/protein kinase B signaling pathways activated function［J］.Chin J obstetrics and gynecology,2014,33(7) :469-473.
［4］Wan Fang,Zhong Gang,He Fuxian,et al.The ERK/MAPK signal pathways activated with invasive breast cancer cell growth［J］.J Medical Graduate Students,2014,6:490-492.
［5］Milde-Langosch K，Bamberger AM，Rieck G，et al.Expression and prognostic relevance of activated extracellular-regulated kinases(ERK1/2) in breast cance［J］.Br J Cancer,2015，92(12):2206-2215.
［6］Mizumoto Y，Kyo S，Mori N，et al.Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis［J］.Cancer Sci,2013，98(5):652-658.
［7］Cai Bing,Ling Liu,Wan Xiaoping,et al.32 examples of intrauterine membrane cancer gene expression profile of hierarchical cluster analysis［J］.Cancer,2012,26(5):456-460.
［8］Friday BB，Adjei AA.Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy［J］.Clin Cancer Res，2013,14(2):342-346.
［9］Wei Shuqin,Sui Lihua,Wei Lihui.Silk crack the original activated protein kinase pathway in the research development of gynecological tumors［J］.Foreign Medical Booklet of Obstetrics and Gynaecology,2014,31(1):51-53.
［10］Wab Xiaoping,Cai Bing,Liu Ling,et al.Not in the same period don't differentially expressed genes in endometrial carcinoma tissue hierarchical clustering analysis［J］.Chinese J Obstetrics and Gynecology,2013,9(1):38-42.
［11］Ferguson SE，Olshen AB，Viale A，et al.Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles［J］.Clin Cancer Res，2015,11:2252-2257.
［12］ Bidus MA，Risinger JI，Chandramouli GV，et al.Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray［J］.Clin Cancer Res,2012，12:83-88.
［13］Maxwell GL，Chandramouli GV，Dainty L，et al.Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer［J］.Clin Cancer Res,2015，11:4056-4066.
［14］Risinger JI，Maxwell GL，Chandramouli GV，et al.Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer［J］.Cancer Res,2013，63(14):6-11.
［15］Zhou Huaijun,Shi Yifu,Li Juanqing.A preliminary study on the gene expression patterns of endometrial adenocarcinoma［J］.J cancer,2013,25(5):464-467.
［16］Meng Yuanguang,Wei Lihui,Wang Jianlu.Application of DNA microarray technology c detection of gene expression profiles in endometrial carcinoma tissue changes［J］.Chin J Medicine,2012,2012(11):665-668.
［17］American college of obstetricians and gynecologists.ACOG practice bulletin，clinical management guidelines for obstetrician-gynecologists，number 65，August 2015:Management of endometrial cancer［J］.Obstet Gynecol,2015,106(88):1489-1495.
［18］Alizadeh AA，Eisen MB，Davis RE，et al.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling［J］.Nature，2014，403:503-511.
［19］Dan-dan sun.Endometrial cancer androgen receptor expression and its correlation with,expression research ［D］.Tianjin:Tianjin Medical University,2012.
［20］Xiaoping Wan.Endometrial carcinoma between estrogen receptor and MAPK signal pathway in regulation［D］.Shanghai:Shanghai Jiaotong University,2014.